Cargando…

Novel appearance of hyperglycemia/diabetes, associated with COVID-19

In a recent meta-analysis the prevalence of coronavirus disease 2019 (COVID-19)-associated hyperglycemia was 25%, and that of COVID-19-associated new-onset diabetes was 19%. An association between hyperglycemia or new-onset diabetes and COVID-19 has been suggested. In a recent relevant study of crit...

Descripción completa

Detalles Bibliográficos
Autor principal: Ilias, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966594/
https://www.ncbi.nlm.nih.gov/pubmed/35433337
http://dx.doi.org/10.5501/wjv.v11.i2.111
_version_ 1784678673616470016
author Ilias, Ioannis
author_facet Ilias, Ioannis
author_sort Ilias, Ioannis
collection PubMed
description In a recent meta-analysis the prevalence of coronavirus disease 2019 (COVID-19)-associated hyperglycemia was 25%, and that of COVID-19-associated new-onset diabetes was 19%. An association between hyperglycemia or new-onset diabetes and COVID-19 has been suggested. In a recent relevant study of critically and non-critically ill patients with COVID-19, we found that indeed beta-cell function was compromised in critically ill patients with COVID-19 and that these patients showed a high glycemic gap. Nevertheless, one quarter of critically ill patients with no history of diabetes have stress hyperglycemia, a finding which could obscure the prevalence of hyperglycemia or new-onset diabetes that could be attributed to COVID-19 per se.
format Online
Article
Text
id pubmed-8966594
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-89665942022-04-14 Novel appearance of hyperglycemia/diabetes, associated with COVID-19 Ilias, Ioannis World J Virol Letter to the Editor In a recent meta-analysis the prevalence of coronavirus disease 2019 (COVID-19)-associated hyperglycemia was 25%, and that of COVID-19-associated new-onset diabetes was 19%. An association between hyperglycemia or new-onset diabetes and COVID-19 has been suggested. In a recent relevant study of critically and non-critically ill patients with COVID-19, we found that indeed beta-cell function was compromised in critically ill patients with COVID-19 and that these patients showed a high glycemic gap. Nevertheless, one quarter of critically ill patients with no history of diabetes have stress hyperglycemia, a finding which could obscure the prevalence of hyperglycemia or new-onset diabetes that could be attributed to COVID-19 per se. Baishideng Publishing Group Inc 2022-03-25 2022-03-25 /pmc/articles/PMC8966594/ /pubmed/35433337 http://dx.doi.org/10.5501/wjv.v11.i2.111 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Ilias, Ioannis
Novel appearance of hyperglycemia/diabetes, associated with COVID-19
title Novel appearance of hyperglycemia/diabetes, associated with COVID-19
title_full Novel appearance of hyperglycemia/diabetes, associated with COVID-19
title_fullStr Novel appearance of hyperglycemia/diabetes, associated with COVID-19
title_full_unstemmed Novel appearance of hyperglycemia/diabetes, associated with COVID-19
title_short Novel appearance of hyperglycemia/diabetes, associated with COVID-19
title_sort novel appearance of hyperglycemia/diabetes, associated with covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966594/
https://www.ncbi.nlm.nih.gov/pubmed/35433337
http://dx.doi.org/10.5501/wjv.v11.i2.111
work_keys_str_mv AT iliasioannis novelappearanceofhyperglycemiadiabetesassociatedwithcovid19